Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Ponsegromab for Heart Failure
Recruiting0 awardsPhase 2
Oklahoma City, Oklahoma
This trial is testing whether a new drug is better than a placebo at treating heart failure symptoms. Participants will be given either the drug or the placebo by injection every four weeks, and won't know which they're getting. The trial will last for nine months.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.